These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Advances in the treatment of Basal cell carcinoma: Hedgehog inhibitors. Kudchadkar R; Lewis K; Gonzalez R Semin Oncol; 2012 Apr; 39(2):139-44. PubMed ID: 22484185 [TBL] [Abstract][Full Text] [Related]
10. Precision medicine and precision therapeutics: hedgehog signaling pathway, basal cell carcinoma and beyond. Mohan SV; Chang AL Semin Cutan Med Surg; 2014 Jun; 33(2):68-71. PubMed ID: 25085664 [TBL] [Abstract][Full Text] [Related]
11. [Sonic Hedgehog signaling pathway: from embryology to molecular targeted therapies]. Watson S; Serrate C; Vignot S Bull Cancer; 2010 Dec; 97(12):1477-83. PubMed ID: 21220225 [TBL] [Abstract][Full Text] [Related]
12. Oral hedgehog-pathway inhibitors for basal-cell carcinoma. Lear JT N Engl J Med; 2012 Jun; 366(23):2225-6. PubMed ID: 22670909 [No Abstract] [Full Text] [Related]
13. Hedgehog Pathway Inhibition for the Treatment of Basal Cell Carcinoma. Gutzmer R; Solomon JA Target Oncol; 2019 Jun; 14(3):253-267. PubMed ID: 31243642 [TBL] [Abstract][Full Text] [Related]
14. Primary cilia can both mediate and suppress Hedgehog pathway-dependent tumorigenesis. Wong SY; Seol AD; So PL; Ermilov AN; Bichakjian CK; Epstein EH; Dlugosz AA; Reiter JF Nat Med; 2009 Sep; 15(9):1055-61. PubMed ID: 19701205 [TBL] [Abstract][Full Text] [Related]
15. Protein kinase A activation inhibits oncogenic Sonic hedgehog signalling and suppresses basal cell carcinoma of the skin. Makinodan E; Marneros AG Exp Dermatol; 2012 Nov; 21(11):847-52. PubMed ID: 23163650 [TBL] [Abstract][Full Text] [Related]
16. Hedgehog signalling in skin development and cancer. Athar M; Tang X; Lee JL; Kopelovich L; Kim AL Exp Dermatol; 2006 Sep; 15(9):667-77. PubMed ID: 16881963 [TBL] [Abstract][Full Text] [Related]
17. Assessment of the adverse events related to hedgehog pathway inhibitor therapy for basal cell carcinoma: A single-centre retrospective study. Villani A; Fabbrocini G; Costa C; Cappello M; Scalvenzi M Australas J Dermatol; 2021 May; 62(2):e296-e297. PubMed ID: 33040336 [No Abstract] [Full Text] [Related]
18. Sonic Hedgehog pathway inhibitors: from clinical trials to clinical practice. Yan BY; Hibler BP; Menge T; Dunn L; Ho AL; Rossi AM Br J Dermatol; 2019 May; 180(5):1260-1261. PubMed ID: 30693471 [No Abstract] [Full Text] [Related]
19. Companies race to develop first Hedgehog inhibitor cancer drug. Dolgin E Nat Med; 2011 May; 17(5):523. PubMed ID: 21546955 [No Abstract] [Full Text] [Related]
20. Hedgehog- and mTOR-targeted therapies for advanced basal cell carcinomas. Piérard-Franchimont C; Hermanns-Lê T; Paquet P; Herfs M; Delvenne P; Piérard GE Future Oncol; 2015 Nov; 11(22):2997-3002. PubMed ID: 26437034 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]